Skip to main content
Tsubota Laboratory Incorporated logo

Tsubota Laboratory Incorporated — Investor Relations & Filings

Ticker · 4890 ISIN · JP3535700003 T Professional, scientific and technical activities
Filings indexed 38 across all filing types
Latest filing 2024-02-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 4890

About Tsubota Laboratory Incorporated

https://tsubota-lab.com/en/

Tsubota Laboratory Incorporated is a research and development company that originated as a startup from Keio University. It is engaged in the creation of pharmaceuticals and medical devices. The company's primary focus is on ophthalmology, developing solutions for conditions such as myopia, dry eye, and presbyopia. Additionally, it explores treatments for central nervous system (CNS) disorders and brain diseases. The corporate strategy centers on out-licensing its developed pipelines to commercial partners. A notable pipeline is a therapeutic candidate designed to curtail the progression of myopia.

Recent filings

Filing Released Lang Actions
四半期報告書-第12期第3四半期(2023/10/01-2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, pursuant to the Financial Instruments and Exchange Act. It contains detailed financial statements, including the balance sheet and income statement for the third quarter of the 12th fiscal year (ending December 31, 2023). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-02-14 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically confirming the accuracy of the contents of a Quarterly Report (Shihanki Hokokusho). While it references a quarterly report, it is a standalone regulatory filing confirming the validity of the financial statements, which falls under the category of general regulatory filings as it does not contain the financial data itself.
2023-11-13 Japanese
四半期報告書-第12期第2四半期(2023/07/01-2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet, income statement, and management analysis for the second quarter of the 12th fiscal period (ending September 30, 2023). It is a comprehensive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2024
2023-11-13 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, Article 24-4-8, Paragraph 1. This is a mandatory regulatory filing in Japan that accompanies quarterly reports to confirm the accuracy of the financial statements. Since it is a specific regulatory filing required by law that does not fit into the primary financial report categories (like 10-K or IR) and is not a mere announcement of a report, it falls under the Regulatory Filings (RNS) category.
2023-08-14 Japanese
四半期報告書-第12期第1四半期(2023/04/01-2023/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Tsubota Laboratory Incorporated, covering the first quarter of the 12th fiscal year (April 1, 2023, to June 30, 2023). It contains detailed financial statements, including the balance sheet and income statement, and is filed under the Financial Instruments and Exchange Act. This fits the definition of an Interim/Quarterly Report (IR). Q1 2024
2023-08-14 Japanese
内部統制報告書-第11期(2022/04/01-2023/03/31)
Regulatory Filings
2023-06-29 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.